These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23026358)

  • 1. Guest editorial: the future of nuclear medicine in the management of CNS diseases.
    Mountz JM
    Semin Nucl Med; 2012 Nov; 42(6):354-5. PubMed ID: 23026358
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of in vivo imaging of the central nervous system for developing novel drugs.
    Rueger MA; Kracht LW; Hilker R; Thiel A; Sobesky J; Winkeler A; Thomas AV; Heneka MT; Graf R; Herholz K; Heiss WD; Jacobs AH
    Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):164-81. PubMed ID: 17420717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of nuclear medicine.
    Ell PJ; Hoejgaard L; Becker W
    Lancet; 2002 Feb; 359(9306):629-30. PubMed ID: 11867148
    [No Abstract]   [Full Text] [Related]  

  • 4. Shaping our future.
    Chiti A
    Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1371-2. PubMed ID: 22820651
    [No Abstract]   [Full Text] [Related]  

  • 5. [Atypical manifestations in superficial siderosis of the central nervous system].
    González-Oria C; Espinosa-Rosso R; Moya-Molina MA; Bejarano-Parra M; Galeano-Bilbao B; Muchada-López MA; Cousido-Martínez-Conde S
    Rev Neurol; 2008 Nov 16-30; 47(10):556. PubMed ID: 19012261
    [No Abstract]   [Full Text] [Related]  

  • 6. Radiopharmaceutical research and production in Brazil: a 30-year history of participation in the nuclear medicine scenario.
    Santos-Oliveira R; Antunes LJ
    J Nucl Med Technol; 2011 Sep; 39(3):237-9. PubMed ID: 21795367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future of nuclear medicine, part 3: assessment of the U.S. therapeutic radiopharmaceuticals market (2001-2020).
    J Nucl Med; 1998 Jul; 39(7):14N, 17N-18N, 20N-22N, 25N, 27N. PubMed ID: 9669377
    [No Abstract]   [Full Text] [Related]  

  • 8. Future of nuclear medicine, part 1: marketing research forecasts.
    J Nucl Med; 1998 Feb; 39(2):27N-30N. PubMed ID: 9476920
    [No Abstract]   [Full Text] [Related]  

  • 9. Postmeeting summary on the round table discussion at the Seventh International Symposium on Technetium in Chemistry and Nuclear Medicine held in Bressanone, Italy on Sept 6-9, 2006.
    Eckelman WC; Erba PA; Schwaiger M; Wagner HN; Alberto R; Mazzi U
    Nucl Med Biol; 2007 Jan; 34(1):1-4. PubMed ID: 17210456
    [No Abstract]   [Full Text] [Related]  

  • 10. Nuclear medicine in the new millennium.
    Phelps ME; Coleman RE
    J Nucl Med; 2000 Jan; 41(1):1-4. PubMed ID: 10647597
    [No Abstract]   [Full Text] [Related]  

  • 11. Current status of nuclear medicine in China.
    Wang SC; Chou C
    Chin Med J (Engl); 2000 May; 113(5):387-91. PubMed ID: 11776089
    [No Abstract]   [Full Text] [Related]  

  • 12. [Radioactive drugs. Modern diagnosis and treatment with "hot drugs"].
    Grillenberger K
    Med Monatsschr Pharm; 2002 Dec; 25(12):418-24. PubMed ID: 12522912
    [No Abstract]   [Full Text] [Related]  

  • 13. Extra-pulmonary manifestations of sarcoidosis.
    Vardhanabhuti V; Venkatanarasimha N; Bhatnagar G; Maviki M; Iyengar S; Adams WM; Suresh P
    Clin Radiol; 2012 Mar; 67(3):263-76. PubMed ID: 22094184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicomorphological classifications of perinatal central nerve system lesions].
    Vlasiuk VV
    Arkh Patol; 2010; 72(6):16-9. PubMed ID: 21400772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Future prospects for nuclear medicine].
    Senda K; Tonami N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Oct; 55(13):508-16. PubMed ID: 8721345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear medicine and chemistry.
    Fowler J
    J Nucl Med; 2002 Jan; 43(1):20N, 22N. PubMed ID: 11820209
    [No Abstract]   [Full Text] [Related]  

  • 17. [Nuclear resonance tomography of the central nervous system; a good use of the possibilities].
    van der Knaap MS; Valk J
    Ned Tijdschr Geneeskd; 1989 Dec; 133(49):2433-8. PubMed ID: 2687705
    [No Abstract]   [Full Text] [Related]  

  • 18. Future of nuclear medicine, part 2: assessment of the U.S. diagnostic radio-pharmaceuticals market (2001-2020).
    J Nucl Med; 1998 Mar; 39(3):20N, 22N-25N. PubMed ID: 9529277
    [No Abstract]   [Full Text] [Related]  

  • 19. [3 cases of diseases of the Creutzfeldt-Jakob group].
    Gaches J; Foncin JF
    Acta Neuropathol; 1967; ():Suppl 3:80-4. PubMed ID: 6074655
    [No Abstract]   [Full Text] [Related]  

  • 20. Veterinary nuclear medicine.
    Krzemiński M; Lass P; Teodorczyk J; Krajka J
    Nucl Med Rev Cent East Eur; 2004; 7(2):177-82. PubMed ID: 15968607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.